Larimar Therapeutics Inc
NASDAQ:LRMR

Watchlist Manager
Larimar Therapeutics Inc Logo
Larimar Therapeutics Inc
NASDAQ:LRMR
Watchlist
Price: 3.26 USD -4.4%
Market Cap: 279m USD

Operating Margin
Larimar Therapeutics Inc

0%
Current
0%
Average
-4.7%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-139.8m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Larimar Therapeutics Inc
Glance View

Market Cap
279m USD
Industry
Biotechnology

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company is headquartered in Bala Cynwyd, Pennsylvania and currently employs 31 full-time employees. The company went IPO on 2014-06-19. The firm is focused on developing treatments for patients suffering from complex rare diseases using its cell penetrating peptide technology platform. The firm's protein replacement therapy platform is intended to deliver missing proteins inside the machinery of cells to treat devastating rare diseases that are ineffective or have no treatments available. Its cell penetrating peptide (CPP) technology platform, which enables a therapeutic molecule to cross a cell membrane in order to reach intracellular targets, has the potential to enable the treatment of other rare and orphan diseases. The firm's lead product candidate, CTI-1601, is a recombinant fusion protein intended to deliver human frataxin (FXN), an essential protein to the mitochondria of patients with Friedreich’s ataxia. CTI-1601 is in a Phase I clinical program.

LRMR Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-139.8m
/
Revenue
0
What is the Operating Margin of Larimar Therapeutics Inc?

Based on Larimar Therapeutics Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top